Do Catheter and Fluid-Path Components Need Biocompatibility Evaluation?

Map direct contact, indirect contact and true non-contact

Draw the clinically used flow path from source to patient. Include the catheter shaft and lumen, distal tip, hub, extension tubing, connector, valve, stopcock, seal, reservoir, filter, port, adhesive, coating, printing ink and lubricant where present. Then identify what touches tissue or circulating blood directly, what contacts a liquid or gas before it reaches the patient, and what is physically isolated in normal and foreseeable use.

“External component” is not the same as “non-contact.” A connector or valve outside the body can create indirect exposure when fluid or gas passes over it before entering the patient, such as in an infusion, ventilation or irrigation pathway. A component used only downstream to collect drained fluid is not automatically an indirect-contact component; assess whether backflow, recirculation, reflux or another plausible patient-return route exists. Conversely, an enclosed component with no plausible transfer path may be outside the biological-evaluation boundary, supported by a design-based rationale.

Classify exposure using the real clinical pathway

Record the nature of contact, tissue or fluid compartment, contact duration, repeated or cumulative use, flow rate and volume, temperature, recirculation, and whether the device introduces, withdraws or contains fluid. FDA's device-category framework treats some catheters as externally communicating devices; the exact category still depends on the design and intended use.

A fluid-path assessment should also identify whether a substance becomes diluted, concentrated, retained or repeatedly introduced. These facts influence exposure analysis, but they should not be used to declare a component irrelevant without evidence.

Evaluate the final finished device state

Component data are useful only when their relationship to the finished system is understood. Document complete formulations, colourants, plasticizers, coatings, adhesives, curing, extrusion or moulding, joining, cleaning, manufacturing aids, sterilization, packaging and aging where relevant. A finished lumen or bonded joint can have a different chemical profile from raw resin or a supplier coupon.

If a supplier's material data or a previously marketed device is used, compare formulation, processing, geometry, exposed area, sterilization and contact pathway. Differences and missing information belong in the uncertainty record.

Build a risk-based evidence strategy

Start from the biological effects relevant to the contact scenario, then decide how each question is addressed. Existing data, material and process knowledge, chemical characterization under ISO 10993-18, toxicological risk assessment under ISO 10993-17 and biological testing can contribute. Chemical characterization can strengthen or redirect the evaluation, but it does not automatically replace every biological endpoint.

• Link each wetted or contacting component to the relevant evidence.
• Explain whether evidence represents the complete finished system or only one material.
• Use exposure assumptions that match clinical flow, duration and frequency.
• Carry unresolved compounds, unknowns, particulates and degradation questions into qualified review.
• Keep sterility, endotoxin, functional performance and biological-safety conclusions distinct.

Choose representative test articles for the question

A family may vary by length, lumen, material, coating, connector or processing site. The configuration with the highest surface area is not necessarily the one with the most challenging formulation, joint, cleaning residue or flow exposure. Use a question-specific representative-device comparison, then carry the selected final-finished configuration into a traceable test-article record.

Where practical limits require a representative portion or pooled article, preserve all relevant wetted materials and do not create unrepresentative cut surfaces. Document what is omitted and why results still apply.

Questions to close for every fluid-path component

1. Can the component, its residue or a released substance reach the patient?
2. What liquid, gas, tissue or blood compartment is involved?
3. What is the maximum and cumulative duration, volume and frequency?
4. Does production, joining, cleaning, sterilization or storage change its exposed state?
5. Which evidence represents the finished component in this pathway?
6. Are formulation, supplier or process differences fully bridged?
7. What chemistry, toxicology or biological questions remain unresolved?

Common catheter and fluid-path mistakes

Common gaps include mapping only the inserted shaft, calling all external parts non-contact, omitting adhesives or lubricants, relying on “medical-grade” statements, applying raw-material data to processed tubing, ignoring repeated flushes or recirculation, and selecting one family article solely by length. A defensible file makes the full exposure path and its evidence visible.